COMMUNIQUÉS West-GlobeNewswire

Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants For Measuring Continuous Blood Glucose
20/06/2018
PhysioTel™ Digital M0G and M1G: Designed to Improve Animal Welfare in Large Animal Models ST. PAUL, Minn. and HOLLISTON, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of [...]
MannKind to Host Institutional Investor and Analyst Meeting
20/06/2018
Renowned Endocrinology Expert Presenting Current Trends in Treatment and Management of Diabetes MannKind’s Chief Medical Officer Presenting New Afrezza ® Data Released at American Diabetes Association’s 78 th Scientific [...]
Oral semaglutide shows statistically significantly greater reductions in HbA1c and weight compared to Victoza® and sitagliptin in the PIONEER 4 and 7 trials
20/06/2018
Bagsværd, Denmark, 20 June 2018 - Novo Nordisk today announced the successful completion and headline results of the phase 3a trials PIONEER 4 comparing oral semaglutide as a treatment for adults with type 2 diabetes to [...]
RavenQuest BioMed Comments on Historic Senate Vote Passing Canada's Cannabis Act
20/06/2018
VANCOUVER, British Columbia, June 20, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (OTCQB:RVVQF) (Franfurt:1IT) (the “ Company ” or “ RavenQuest ”) comments on the historic vote in Canada's upper chamber on [...]
ContraVir Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
20/06/2018
EDISON, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis
20/06/2018
LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an agreement to acquire Boston- [...]
Bio-on inaugurates in Italy the first special bioplastics production plant. 100% natural and biodegradable
20/06/2018
20 million Euro investment behind new production hub, the first owned by Bio-on. Highly sustainable project converted from a former factory: occupies no new land and is powered by electric energy generated by an [...]
Bio-on inaugure, en Italie, son premier établissement de production de bioplastiques spéciaux, naturels et entièrement (100%) biodégradables
20/06/2018
Les investissements dans ce nouvel établissement de production, le premier de propriété Bio-on, se chiffrent à 20 millions d'euros. Il s'agit d'un projet hautement durable, issu de la conversion d'une ancienne usine, [...]
Is pot bad for your heart? Truth is… we don’t know yet
20/06/2018
OTTAWA, June 20, 2018 (GLOBE NEWSWIRE) -- As the Canadian Senate officially passes Bill C-45 on Marijuana legalization, the University of Ottawa Heart Institute (UOHI) has looked at the effects of marijuana on the heart [...]
Le pot, inoffensif pour le cœur? Pas si vite…
20/06/2018
OTTAWA, 20 juin 2018 (GLOBE NEWSWIRE) -- Le Sénat du Canada vient d’adopter le projet de loi C-45, portant sur la légalisation de la marijuana. L’Institut de cardiologie de l’Université d’Ottawa en profite pour se [...]
Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures
20/06/2018
Delivering Commitment to Find New Treatment Options for Patients Suffering from Sacral Insufficiency Fractures DUBLIN - June 20, 2018- Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA [...]
Easton Pharmaceuticals Announces New Director / Officer to Its Board and Updates to Business Direction
20/06/2018
TORONTO, ON, June 20, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH ) is pleased to announce a new director and officer to its board with the appointment of Mr. Vince Demasi of Alliance Group, as Chief [...]
Teligent, Inc. Announces FDA Approval of Fluocinonide Gel, 0.05%
20/06/2018
BUENA, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Keryx Biopharmaceuticals Announces Participation in a Renal Disease Panel at the JMP Securities Life Sciences Conference on Thursday, June 21st
20/06/2018
BOSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced participating [...]
Paratek Announces FDA Advisory Committee Date for Omadacycline
20/06/2018
BOSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
NewLink Genetics Announces Updated Data for Indoximod Plus Radio-Immunotherapy in DIPG to be Presented at ISPNO 2018 Meeting
20/06/2018
AMES, Iowa, June 20, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that updated data for patients with diffuse intrinsic pontine glioma (DIPG) from NLG2105 , a Phase 1 study [...]
Agritek Holdings, Inc. Applauds Move By Canada That Just Legalized Marijuana Bringing Big Implications And Paving Way For New US Drug Policy
20/06/2018
Canada Now the Second Country in the World to Legalize Cannabis, Following Uruguay LOS ANGELES, CA, June 20, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, [...]
Zosano Announces Publication on Adhesive Dermally-Applied Microarray (ADAM™) Technology for the Delivery of Zolmitriptan in Migraine in Journal of Pharmaceutics
20/06/2018
Peer reviewed article evaluates effect of skin models on in vitro performance of ADAM FREMONT, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical- [...]
Alder BioPharmaceuticals® to Present New Data Further Highlighting Eptinezumab’s Efficacy Profile for Migraine Prevention at American Headache Society Meeting
20/06/2018
New eptinezumab data at two late-breaking sessions demonstrate efficacy that is sustained and further improved after repeat treatments BOTHELL, Wash., June 20, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ( [...]

Pages